Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prodia Diacro Laboratories is a premier Contract Research Organization (CRO) based in Indonesia, specializing in providing end-to-end clinical research services. The company supports pharmaceutical and biotechnology firms in conducting Phase I-IV clinical trials, bioequivalence studies, and medical device investigations. Their core competencies include regulatory affairs, site management, clinical monitoring, data management, and biostatistics. By leveraging its partnership with the Prodia Group's extensive laboratory network, Prodia Diacro offers high-quality diagnostic support and ensures compliance with international Good Clinical Practice (GCP) standards. It serves as a strategic partner for global companies looking to navigate the Indonesian and Southeast Asian regulatory landscapes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prodia Diacro Laboratories.